Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Felbinac Trometamol Eye Drops in Healthy Subjects
NCT05085106Phase 1Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of felbinac in post-operative inflammation (8 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Ophthalmic examination results, Intraocular pressure values and 2 more. Status: unknown.
02
Drugs
felbinac
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on NCT05085106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05085106.